Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

 Dow Down 1.33% Nasdaq Down 2.33%
Alexion Pharmaceuticals, Inc. (ALXN)On May 7: 50.25  Down 1.88 (3.61%)  
More on ALXN
Quotes
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
HereIncome Statement

Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2009Sep 30, 2009Mar 31, 2009Dec 31, 2008
Total Revenue 110,649   102,628   81,267   77,399  
Cost of Revenue12,892  11,895  9,959  6,812  
Gross Profit 97,757   90,733   71,308   70,587  
Operating Expenses
Research Development23,215  21,323  19,089  15,275  
Selling General and Administrative51,887  41,523  36,652  38,789  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 22,655   27,887   15,567   16,523  
Income from Continuing Operations
Total Other Income/Expenses Net23  (125)(90)657  
Earnings Before Interest And Taxes22,678  27,762  15,477  17,180  
Interest Expense84  80  333  432  
Income Before Tax22,594  27,682  15,144  16,748  
Income Tax Expense(214,533)951  638  1,412  
Minority Interest -   -   -   -  
Net Income From Continuing Ops237,127  26,731  14,506  15,336  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 237,127   26,731   14,506   15,336  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares $237,127   $26,731   $14,506   $15,336  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More